Tetraphase Pharmaceuticals, Inc. (TTPH)

[rusty8350]

Way I read this, the drug works for infra-abdominal infections but these new results say it doesn't work for urinary tract infections. 80% drop when the drug works, doesn't seem justified. And the company has plenty of other stuff going on as well. I believe this will rebound significantly from here.



"We previously announced positive data from the IGNITE1 phase 3 clinical trial of eravacycline administered intravenously in complicated intra-abdominal infections which did meet its primary endpoint, demonstrating high cure rates in prevalent Gram-negative pathogens and a favorable safety profile."

Macdonald added, "We continue to believe that eravacycline can benefit patients with serious infections, particularly those caused by difficult-to-treat Gram-negative bacteria."